
First-Line Immunotherapy Prolongs Life in Advanced Head & Neck Cancer
Author(s) -
Peter M. Goodwin
Publication year - 2018
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000550421.01184.41
Subject(s) - pembrolizumab , medicine , head and neck cancer , oncology , carboplatin , chemotherapy , cancer , immunotherapy , cisplatin , surgery